CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/21/2026

1. INTC
2. DSX
3. GNK
4. TTEC
5. DAL
6. AWK
7. SPCX
8. III
9. TEVA
10. FCLI

Go back to CAMP4 Therapeutics to Present New Preclinical Data Demonstrating CMP-002 Improves Seizure Threshold and Severity in a Model of SYNGAP1-Related Disorder
CalAmp Corp. (NASDAQ: CAMP) Delayed: 4.13 -0.01 (0.24%)
Previous Close $4.14    52 Week High $21.34 
Open $4.29    52 Week Low $12.13 
Day High $4.45    P/E 3.11 
Day Low $3.92    EPS $1.33 
Volume 161,146